Literature DB >> 3622162

Do size, histology, or cytology of colorectal adenomas and their removal influence serum CEA?

W Fischbach, J Mössner.   

Abstract

Based on the adenoma-carcinoma sequence the authors studied whether determination of serum carcinoembryonic antigen (CEA) provided any conclusions concerning malignant transformation of a colorectal adenoma. In 32 patients with single or multiple adenomas, serum CEA did not differ from 119 healthy individuals. In 43 percent, a decrease of CEA could be observed after polypectomy, while it increased in 22 percent or remained unchanged in 35 percent. No correlation was found between adenoma volume and serum CEA. There was a tendency toward a higher serum CEA level in patients with villous adenoma as compared with those with tubular structure. CEA concentrations were independent from the degree of cellular atypia, but polypectomy was followed by a decrease of serum CEA in villous adenoma or of moderate cellular atypia, reflecting a possible influence on production or shedding of CEA by these subtypes of adenoma. The results indicate, therefore, that serum CEA is not able to recognize the malignant potential of colorectal adenoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622162     DOI: 10.1007/bf02554805

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  2 in total

1.  Should a colonoscopy be recommended for healthy individuals with increased carcinoembryonic antigen levels? A case-control study.

Authors:  Jin Ha Lee; Sung Pil Hong; Tae Joo Jeon; Gun-Hi Kang; Won-Choong Choi; Soung Min Jeon; Chang Mo Moon; Jae Jun Park; Jae Hee Cheon; Tae Il Kim; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2011-02-17       Impact factor: 3.199

2.  Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia.

Authors:  Nam Hee Kim; Mi Yeon Lee; Jung Ho Park; Dong Il Park; Chong Il Sohn; Kyuyong Choi; Yoon Suk Jung
Journal:  Yonsei Med J       Date:  2017-09       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.